On this page
Epitalon is a lab-made peptide of four amino acids that has mainly been studied in research on telomeres in lab-grown cells and on the pineal gland in animals [G1, G2]. Researchers have also measured how long fruit flies and mice lived when given it, and which genes changed activity in cells and tissue [G5, G6, G9, G10]. Most of this work was done in cells and animals: 24 of the 28 studies in one review [G1].
What is Epitalon?
A peptide is a short chain of amino acids, the building blocks of proteins. Epitalon has four: alanine, glutamic acid, aspartic acid and glycine, written Ala-Glu-Asp-Gly or AEDG [G2]. It is also spelled Epithalon or Epithalone [G2].
It was designed from the amino-acid makeup of Epithalamin, an extract of cattle pineal glands [G2]. The pineal gland is a small gland in the brain that makes the hormone melatonin. Epitalon was developed by Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology [G1]. In 2017, it was reported for the first time in a pineal gland extract [G2].
Epitalon and Epithalamin are chemically different preparations, and a 2026 review states that their evidence should not be treated as interchangeable [G1].
What is Epitalon used for?
In research, Epitalon has mainly been studied for:
- Telomeres and telomerase in human cells grown in the lab. Telomeres are the protective caps on the ends of chromosomes. Telomerase is the enzyme that rebuilds them. Researchers looked at whether the enzyme switched on and whether telomeres got longer [G3, G4].
- The pineal gland and melatonin in monkeys and rats. One study measured melatonin and cortisol in monkeys of different ages [G7]. Another measured melatonin release from rat pineal glands kept alive in a lab device [G8].
- Lifespan in fruit flies and mice. Researchers recorded how long animals lived compared with untreated animals [G5, G6].
- Gene expression in cells and tissue. Gene expression means which genes are switched on or off. Researchers looked at this in human stem cells and in mouse heart tissue [G9, G10].
Reviewers who surveyed the field describe how Epitalon works as still unclear [G2].
Epitalon research areas at a glance
| Area | What researchers looked at | Models | How strong the evidence is |
|---|---|---|---|
| Telomeres and telomerase | Whether telomerase switched on and telomeres got longer in cells exposed to Epitalon [G3, G4] | Human fetal fibroblasts [G3]; normal human fibroblast and breast-tissue cell lines, and two breast cancer cell lines [G4] | Cell studies only. One independent lab tested telomere lengthening in other human cells, and its paper was later corrected [G1, G4] |
| Pineal gland and melatonin | Melatonin and cortisol levels in monkeys of different ages; melatonin release from isolated pineal glands [G7, G8] | Female rhesus monkeys [G7]; pineal glands from young and old rats, in a lab device [G8] | Animal and tissue studies with mixed results: increased evening melatonin production reported in old monkeys [G7], no change in isolated rat pineal glands [G8] |
| Lifespan | How long animals lived compared with untreated controls [G5, G6] | Fruit flies [G5]; female mice [G6] | Animal studies from the originating group. In mice, average lifespan did not change [G6] |
| Gene expression | Which genes became more or less active [G9, G10] | Human gum-tissue stem cells [G9]; mouse heart tissue [G10]; computer modelling [G9] | Cell, animal-tissue and computer-modelling studies [G9, G10] |
| Studies in people | Small physiological or biomarker studies, and one older controlled study in people with retinitis pigmentosa [G1] | — | No adequately powered randomised trial has established a clinical result [G1] |
Evidence levels follow the sources; the human row summarises the review by Jain et al. [G1].
How is Epitalon thought to work?
Every finding below comes from cells, tissue, animals or computer models.
Telomerase. Fibroblasts are the cells that make connective tissue. In human fetal fibroblasts that had no telomerase activity, Khavinson et al. reported that adding Epitalon induced expression of the enzyme's catalytic subunit (its working part), raised telomerase activity and lengthened telomeres [G3]. In two kinds of normal (non-cancer) human cells grown in the lab, fibroblasts and breast-tissue cells, Al-Dulaimi et al. reported telomere lengthening, with more hTERT mRNA (the gene message for the enzyme's working part) and higher telomerase activity [G4]. In two breast cancer cell lines, telomeres lengthened through ALT (alternative lengthening of telomeres), a route that does not use telomerase [G4]. ALT rose only slightly in the normal cells [G4].
Pineal signalling. In female rhesus monkeys, Khavinson's group measured melatonin and cortisol by immunoassay [G7]. The group reported increased evening melatonin production in old monkeys, and a change in their daily cortisol rhythm [G7]. A Paris-based study, with Khavinson and Anisimov as co-authors, used perifusion: pineal glands from 9-week-old and 27-month-old rats were kept in a flowing nutrient solution [G8]. The peptide had no significant effect on melatonin release at either age [G8]. It also did not change the melatonin rise triggered by isoproterenol, a drug that stimulates the gland's beta-adrenergic receptors [G8]. The authors concluded it "does not seem to play a role, at least in vitro, in the control of melatonin secretion" [G8]. Jain et al. read these results as showing that the reported hormone effects "may depend on experimental context" [G1].
Gene regulation. In stem cells from human gum tissue, AEDG increased the gene messages and proteins of four markers of nerve-cell development: Nestin, GAP43, β-Tubulin III and Doublecortin [G9]. Computer modelling suggested it binds histones H1/3 and H1/6, proteins that package DNA, at sites that touch the DNA [G9]. The authors proposed this as a possible epigenetic mechanism, meaning a change in how genes are read rather than in the DNA itself [G9]. In mouse heart tissue, a DNA microarray (a chip that tracks thousands of genes at once) screened 15,247 clones; Epitalon changed the expression of 98 of them more than two-fold [G10].
Araj et al. concluded that the mechanism "remains unclear", and that it is not known whether the reported routes are the only ones [G2].
What kind of studies are these?
Studies come in three broad kinds. Cell studies (in vitro) test a compound on cells in a dish. Animal studies test it in a whole living animal, but not in a person. Human trials are the only way to learn what happens in people. Most Epitalon research is the first two kinds [G1].
Epitalon was developed and extensively studied by Khavinson's group in St Petersburg [G1]. An independent 2026 review described the literature as "concentrated within a small number of research groups" and found that independent replication "remains limited" [G1].
In fruit flies, Epitalon was added to the culture medium only while the flies developed from egg to larva; the group reported that the adult flies lived longer than controls, and that the effect did not depend on concentration [G5]. In mice, 54 females per group received Epitalon or saline from 3 months of age until they died [G6]. Food intake, body weight and average lifespan did not change [G6]. The group reported longer survival among the longest-lived mice [G6]. Estrous (reproductive) cycles and chromosome defects in bone-marrow cells were also recorded [G6]. One independent lab, at Brunel University London, tested in 2025 whether Epitalon lengthened telomeres in other human cells, and reported telomere lengthening [G4]. The journal later published a correction that replaced three of the paper's figures, and Jain et al. advise reading its telomerase findings cautiously [G1, G4]. The authors themselves name their main limit: an in vitro study in 2D (flat-layer) cell cultures [G4].
Research in people is limited to small physiological or biomarker studies and one older controlled study in people with retinitis pigmentosa, an inherited eye disease [G1]. Jain et al. report that no adequately powered randomised trial in people has established a clinical result [G1].
For a similar map of another research peptide, see What is BPC-157 used for in research? Back to the Limitless Science home page.
Sources
- [G1] Jain A, Gallacher D, Issa M, et al. Int J Mol Sci. 2026;27(19):8922. doi:10.3390/ijms27198922 (PMC13664938).
- [G2] Araj SK, Brzezik J, Mądra-Gackowska K, Szeleszczuk Ł. Int J Mol Sci. 2025;26(6):2691. doi:10.3390/ijms26062691. PMID 40141333.
- [G3] Khavinson VKh, Bondarev IE, Butyugov AA. Bull Exp Biol Med. 2003;135(6):590–592. doi:10.1023/a:1025493705728. PMID 12937682.
- [G4] Al-Dulaimi S, Thomas R, Matta S, Roberts T. Biogerontology. 2025;26(5):178. doi:10.1007/s10522-025-10315-x. PMID 40908429. Correction: Biogerontology. 2026;27(1):1. doi:10.1007/s10522-025-10326-8. PMID 41240216.
- [G5] Khavinson VK, Izmaylov DM, Obukhova LK, Malinin VV. Mech Ageing Dev. 2000;120(1–3):141–149. doi:10.1016/s0047-6374(00)00217-7. PMID 11087911.
- [G6] Anisimov VN, Khavinson VKh, Popovich IG, et al. Biogerontology. 2003;4(4):193–202. doi:10.1023/a:1025114230714. PMID 14501183.
- [G7] Khavinson V, Goncharova N, Lapin B. Neuro Endocrinol Lett. 2001;22(4):251–254. PMID 11524632.
- [G8] Djeridane Y, Khavinson VKh, Anisimov VN, Touitou Y. J Endocrinol Invest. 2003;26(3):211–215. doi:10.1007/BF03345159. PMID 12809170.
- [G9] Khavinson V, Diomede F, Mironova E, et al. Molecules. 2020;25(3):609. doi:10.3390/molecules25030609. PMID 32019204.
- [G10] Anisimov SV, Bokheler KR, Khavinson VKh, Anisimov VN. Bull Exp Biol Med. 2002;133(3):293–299. doi:10.1023/a:1015859322630. PMID 12360356.
All products are sold for laboratory research use only. Not for human or veterinary use. Nothing on this page is medical advice.